Vitamin D deficiency is common among patients with cirrhosis, and it has been linked to various complications, including frailty, muscle weakness, and poor clinical outcomes. This article explores the impact of correcting vitamin D deficiency in decompensated cirrhotic patients, with a focus on frailty improvement. Data from clinical studies suggest that vitamin D supplementation can lead to improvements in frailty scores, muscle strength, and overall functional capacity. This review highlights the importance of early diagnosis and treatment of vitamin D deficiency in cirrhotic patients and the potential role of vitamin D as a therapeutic adjunct in managing frailty and improving quality of life.

Vitamin D deficiency, decompensated cirrhosis, muscle weakness

Tandon, P.; Montano-Loza, A.J.; Lai, J.C.; Dasarathy, S.; Merli, M. Sarcopenia and frailty in decompensated cirrhosis. J. Hepatol. 2021, 75 (Suppl. 1), S147–S162. [Google Scholar] [CrossRef]

Wang, S.; Whitlock, R.; Xu, C.; Taneja, S.; Singh, S.; Abraldes, J.G.; Burak, K.W.; Bailey, R.J.; Lai, J.C.; Tandon, P. Frailty is associated with increased risk of cirrhosis disease progression and death. Hepatology 2022, 75, 600–609. [Google Scholar] [CrossRef] [PubMed]

Román, E.; Parramón, M.; Flavià, M.; Gely, C.; Poca, M.; Gallego, A.; Santesmases, R.; Hernández, E.; Nieto, J.C.; Urgell, E.; et al. Frailty in outpatients with cirrhosis: A prospective observational study. Liver Int. 2021, 41, 357–368. [Google Scholar] [CrossRef] [PubMed]

Kappus, M.R.; Mendoza, M.S.; Nguyen, D.; Medici, V.; McClave, S.A. Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise? Curr. Gastroenterol. Rep. 2016, 18, 43. [Google Scholar] [CrossRef] [PubMed]

Paul, S.; Kaushik, R.; Chawla, P.; Upadhyay, S.; Rawat, D.; Akhtar, A. Vitamin-D as a multifunctional molecule for overall well-being: An integrative review. Clin. Nutr. ESPEN 2024, 62, 10–21. [Google Scholar] [CrossRef]

Russo, C.; Santangelo, R.; Malaguarnera, L. Valle MS. The “Sunshine Vitamin” and Its Antioxidant Benefits for Enhancing Muscle Function. Nutrients 2024, 16, 2195. [Google Scholar] [CrossRef]

Anilkumar, S.A.; Dutta, S.; Aboo, S.; Ismail, A. Vitamin D as a modulator of molecular pathways involved in CVDs: Evidence from preclinical studies. Life Sci. 2024, 357, 123062. [Google Scholar] [CrossRef] [PubMed]

Androutsakos, T.; Politou, M.; Boti, S.; Pittaras, T.; Kontos, A.; Kordossis, T.; Pouliakis, A.; Panayiotakopoulos, G. Prevalence and Causes of Vitamin D Deficiency in a Cohort of Greek HIV-Infected Individuals: A Prospective, Single Centre, Observational Study. Curr. HIV Res. 2024, 22, 240–248. [Google Scholar] [CrossRef] [PubMed]

Wang, P.; Chen, J.; Li, Z.; Xiong, H.; Lei, Z.; Chen, D.; Zhang, Y.; Gao, Z.; Mo, Z. Association of vitamin D with functional cure in chronic hepatitis B: Insights from a retrospective cohort study and an intervention study. Clin. Nutr. ESPEN 2024, 64, 244–252. [Google Scholar] [CrossRef] [PubMed]

Chen, L.; Zhou, T.; Lv, C.; Ni, H.; Zhao, Z.; Zhou, H.; Hu, X. Vitamin D supplementation can improve the 28-day mortality rate in patients with sepsis-associated acute kidney injury. Ren. Fail. 2024, 46, 2431632. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]

Okubo, T.; Atsukawa, M.; Tsubota, A.; Ono, H.; Kawano, T.; Yoshida, Y.; Arai, T.; Hayama, K.; Itokawa, N.; Kondo, C.; et al. Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial. Nutrients 2021, 13, 1874. [Google Scholar] [CrossRef] [PubMed]

Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911–1930. [Google Scholar] [CrossRef] [PubMed]

Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Ross, A.C., Taylor, C.L., Yaktine, A.L., Del Valle, H.B., Eds.; Dietary Reference Intakes for Calcium and Vitamin D; National Academies Press (US): Washington DC, USA, 2011. Available online: https://www.ncbi.nlm.nih.gov/books/NBK56070/ (accessed on 1 January 2017). [CrossRef]

Wang, J.; Thornton, J.C.; Kolesnik, S.; Pierson, R.N., Jr. Anthropometry in body composition. An overview. Ann. N. Y. Acad. Sci. 2000, 904, 317–326. [Google Scholar] [CrossRef] [PubMed]

Fried, L.P.; Tangen, C.M.; Walston, J.; Newman, A.B.; Hirsch, C.; Gottdiener, J.; Seeman, T.; Tracy, R.; Kop, W.J.; Burke, G.; et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J. Gerontol. A. Biol. Sci. Med. Sci. 2001, 56, M146–M156. [Google Scholar] [CrossRef]

Bergstrom, N.; Braden, B.J.; Laguzza, A.; Holman, V. The Braden Scale for Predicting Pressure Sore Risk. Nurs. Res. 1987, 36, 205–210. [Google Scholar] [CrossRef]

Centre for Metabolic Bone Diseases UoSU. FRAX WHO Fracture Risk Assessment Tool. 2020. Available online: https://www.sheffield.ac.uk/FRAX/ (accessed on 15 July 2023).

Kerr, G.K.; Worringham, C.J.; Cole, M.H.; Lacherez, P.F.; Wood, J.M.; Silburn, P.A. Predictors of future falls in Parkinson disease. Neurology 2010, 75, 116–124. [Google Scholar] [CrossRef]

Soriano, G.; Román, E.; Córdoba, J.; Torrens, M.; Poca, M.; Torras, X.; Villanueva, C.; Gich, I.J.; Vargas, V.; Guarner, C. Cognitive dysfunction in cirrhosis is associated with falls: A prospective study. Hepatology 2012, 55, 1922–1930. [Google Scholar] [CrossRef]

Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyère, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.; Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019, 48, 16–31. [Google Scholar] [CrossRef]

Alonso, J.; Prieto, L.; Antó, J.M. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results. Med. Clin. 1995, 104, 771–776. [Google Scholar]

Ferrer, M.; Córdoba, J.; Garin, O.; Olivé, G.; Flavià, M.; Vargas, V.; Esteban, R.; Alonso, J. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2006, 12, 95–104. [Google Scholar] [CrossRef]

Herrmann, C. International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J. Psychosom. Res. 1997, 42, 17–41. [Google Scholar] [CrossRef]